FDA Approves First Drug for Rare Lipid Storage Disorder
MedPage Today) — The FDA on Friday approved chenodiol (Ctexli) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Chenodiol — a naturally occurring human bile acid also known as chenodeoxycholic acid — is the first FDA…
MedPage Today) — The FDA on Friday approved chenodiol (Ctexli) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.
Chenodiol — a naturally occurring human bile acid also known as chenodeoxycholic acid — is the first FDA…
Read More
About Author
